These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29052158)

  • 1. Estimating Health State Utility Values for Comorbidities.
    Ara R; Brazier J
    Pharmacoeconomics; 2017 Dec; 35(Suppl 1):89-94. PubMed ID: 29052158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using health state utility values in models exploring the cost-effectiveness of health technologies.
    Ara R; Wailoo A
    Value Health; 2012; 15(6):971-4. PubMed ID: 22999149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing EQ-5D scores for comorbid health conditions estimated using 5 different methods.
    Ara R; Brazier J
    Med Care; 2012 May; 50(5):452-9. PubMed ID: 22002647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating health state utility values for joint health conditions: a conceptual review and critique of the current evidence.
    Ara R; Wailoo AJ
    Med Decis Making; 2013 Feb; 33(2):139-53. PubMed ID: 22927696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating Joint Health Condition Utility Values.
    Thompson AJ; Sutton M; Payne K
    Value Health; 2019 Apr; 22(4):482-490. PubMed ID: 30975400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Use of Mapping to Estimate Health State Utility Values.
    Ara R; Rowen D; Mukuria C
    Pharmacoeconomics; 2017 Dec; 35(Suppl 1):57-66. PubMed ID: 29052160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Evidence for Key Parameters in Decision-Analytic Models of Cost Effectiveness: A Description of Sources and a Recommended Minimum Search Requirement.
    Paisley S
    Pharmacoeconomics; 2016 Jun; 34(6):597-608. PubMed ID: 26861793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Populating an economic model with health state utility values: moving toward better practice.
    Ara R; Brazier JE
    Value Health; 2010 Aug; 13(5):509-18. PubMed ID: 20230546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Use of Health State Utility Values in Decision Models.
    Ara R; Brazier J; Zouraq IA
    Pharmacoeconomics; 2017 Dec; 35(Suppl 1):77-88. PubMed ID: 29052163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating health state utility values for comorbid health conditions using SF-6D data.
    Ara R; Brazier J
    Value Health; 2011; 14(5):740-5. PubMed ID: 21839413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic literature review of health state utility values in head and neck cancer.
    Meregaglia M; Cairns J
    Health Qual Life Outcomes; 2017 Sep; 15(1):174. PubMed ID: 28865475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health state utility values among children and adolescents with disabilities: protocol for a systematic review.
    Kanya L; Anokye N; Ryan JM
    BMJ Open; 2018 Feb; 8(2):e019978. PubMed ID: 29467137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic searching and selection of health state utility values from the literature.
    Papaioannou D; Brazier J; Paisley S
    Value Health; 2013 Jun; 16(4):686-95. PubMed ID: 23796303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward a Centralized, Systematic Approach to the Identification, Appraisal, and Use of Health State Utility Values for Reimbursement Decision Making: Introducing the Health Utility Book (HUB).
    Xie F; Zoratti M; Chan K; Husereau D; Krahn M; Levine O; Clifford T; Schunemann H; Guyatt G
    Med Decis Making; 2019 May; 39(4):370-378. PubMed ID: 30902030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is Meta-Analysis for Utility Values Appropriate Given the Potential Impact Different Elicitation Methods Have on Values?
    Peasgood T; Brazier J
    Pharmacoeconomics; 2015 Nov; 33(11):1101-5. PubMed ID: 26133293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in the Selection of Health State Utility Values by Sponsorship in Published Cost-Effectiveness Analyses.
    Hendrix N; Kim DD; Patel KS; Devine B
    Med Decis Making; 2021 Apr; 41(3):366-372. PubMed ID: 33451278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the predictive accuracy of health-state utility values based on the Lloyd model for metastatic or recurrent breast cancer in Japan.
    Iwatani T; Inoue E; Tsugawa K
    BMJ Open; 2021 Dec; 11(12):e046273. PubMed ID: 34853098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical appraisal of health-state utility values used in breast cancer-related cost-utility analyses.
    Nerich V; Saing S; Gamper EM; Holzner B; Pivot X; Viney R; Kemmler G
    Breast Cancer Res Treat; 2017 Aug; 164(3):527-536. PubMed ID: 28497177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring health state utility values of parents of children with a serious illness.
    Majmudar IK; Engel L; Muscara F; Stevenson C; McCarthy M; Anderson V; Mihalopoulos C
    Qual Life Res; 2020 Jul; 29(7):1947-1959. PubMed ID: 32335816
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.